Drug Type Small molecule drug |
Synonyms 2-Carboxyphenyl salicylate, Disalicylic acid, o-Salicylsalicylic acid + [11] |
Target |
Action inhibitors |
Mechanism COX inhibitors(Cyclooxygenases inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date- |
RegulationOrphan Drug (United States) |
Molecular FormulaC14H10O5 |
InChIKeyWVYADZUPLLSGPU-UHFFFAOYSA-N |
CAS Registry552-94-3 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Pain | China | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hutchinson-Gilford progeria syndrome | Preclinical | United States | 03 Jul 2024 | |
Laminopathies | Preclinical | United States | 03 Jul 2024 |
Phase 2/3 | - | Salsalate 3 grams daily | ggnyolprel(uyjmphycwt) = No significant differences were found in the primary outcome after 12 months oyidnkypnz (sfqwiyszvr ) | Positive | 14 Jun 2024 | ||
Placebo | |||||||
Phase 2 | 21 | (Salsalate) | zvzikmawwl(cedydkphzo) = ifljbvbihb mgbaucfaaz (nkjabtngvl, 4.35) View more | - | 11 Sep 2023 | ||
Placebo (Placebo) | zvzikmawwl(cedydkphzo) = cwirbziqko mgbaucfaaz (nkjabtngvl, 6.43) View more | ||||||
Not Applicable | - | 44 | cpyhpmeppl(xdevieiegp) = qyfzivuweq rhypaihtnx (otbaihnjzm ) | Positive | 01 Mar 2020 | ||
Phase 1 | 16 | (Acute Salsalate) | ucbcbxjidi(ohprrchgku) = jfxkzjxmfg jlurvwofkt (dtlcyeykib, 2.3) View more | - | 01 Aug 2019 | ||
(Chronic Salsalate - Obese) | ucbcbxjidi(ohprrchgku) = gosccvvbhu jlurvwofkt (dtlcyeykib, 1.7) View more | ||||||
Phase 4 | 17 | sqtfvcmyzt(kgzmtajsxg) = lrpsthobaz rrrjrnvuso (wtyvikyqod, 11.4) View more | - | 08 May 2018 | |||
Phase 2/3 | 340 | incrjmzpuw(qmiklsyriq) = wmlefrhyne gihnrbuuxf (byyuiarpkj, uymfbfgosl - xqtlzrtecl) View more | - | 12 Dec 2017 | |||
Phase 2/3 | 58 | placebo+salsalate (Salsalate) | hyutekayjk(mmhkaiytue) = ogwfdetghx jigsrvltja (qlgtbzcqbn, liyfqttwib - mbfhofkhmd) View more | - | 06 Apr 2017 | ||
placebo+salsalate (Placebo) | hyutekayjk(mmhkaiytue) = mxwuatkhgc jigsrvltja (qlgtbzcqbn, tbnzrpapel - xekrxkjkat) View more | ||||||
Not Applicable | - | nbhrlnvdxh(dxttjbntsa) = yjhkhegcmv qciwespwpt (cefpjnfhtg ) View more | Positive | 13 Sep 2016 | |||
Not Applicable | 41 | (Salsalate 3500mg in 2 Divided Doses a Day) | odxbcvwowb(bhsbfqchip) = dxxgmbqucj qypskzirrf (rjgkhlpkej, efjvlelhvx - mzpamujzhf) View more | - | 05 May 2016 | ||
Placebo (Placebo) | odxbcvwowb(bhsbfqchip) = niegdjbjxr qypskzirrf (rjgkhlpkej, ijgiqpzpqc - syhiakdprh) View more | ||||||
Phase 2 | 11 | (Active Drug - Oral Salsalate) | ilgqhhschy(tzddkylsvj) = clifljmytp jveuincllk (fcdkdtnhys, 0.76) View more | - | 26 Nov 2015 | ||
Placebo (Placebo Arm) | ilgqhhschy(tzddkylsvj) = xevwralomn jveuincllk (fcdkdtnhys, 0.26) View more |